Several other research analysts also recently commented on the stock. Jefferies Group LLC reissued a buy rating and set a $33.00 price target on shares of Wright Medical Group N.V. in a research note on Thursday, October 12th. Robert W. Baird reissued a buy rating and set a $33.00 price target on shares of Wright Medical Group N.V. in a research note on Friday, October 6th. Royal Bank Of Canada reissued a buy rating and set a $31.00 price target on shares of Wright Medical Group N.V. in a research note on Tuesday, October 3rd. BidaskClub upgraded shares of Wright Medical Group N.V. from a sell rating to a hold rating in a report on Friday, August 11th. Finally, Piper Jaffray Companies restated a buy rating and issued a $34.00 target price on shares of Wright Medical Group N.V. in a report on Thursday, August 3rd. Six research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The stock has an average rating of Buy and an average target price of $32.22.
Wright Medical Group N.V. (WMGI) opened at $23.68 on Thursday. The company has a debt-to-equity ratio of 1.52, a current ratio of 1.31 and a quick ratio of 0.96. Wright Medical Group N.V. has a 1 year low of $22.14 and a 1 year high of $31.53.
Wright Medical Group N.V. (NASDAQ:WMGI) last released its quarterly earnings data on Wednesday, November 1st. The medical device company reported ($0.16) EPS for the quarter, meeting analysts’ consensus estimates of ($0.16). The company had revenue of $170.50 million during the quarter, compared to analyst estimates of $173.50 million. Wright Medical Group N.V. had a negative net margin of 38.40% and a negative return on equity of 6.27%. Wright Medical Group N.V.’s revenue was up 8.4% compared to the same quarter last year. During the same period last year, the business earned ($0.19) earnings per share. sell-side analysts expect that Wright Medical Group N.V. will post -0.28 earnings per share for the current fiscal year.
In other Wright Medical Group N.V. news, Director Richard F. Wallman purchased 4,000 shares of the company’s stock in a transaction on Friday, November 10th. The stock was acquired at an average cost of $24.00 per share, for a total transaction of $96,000.00. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Gregory Morrison sold 92,140 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $23.70, for a total value of $2,183,718.00. The disclosure for this sale can be found here. Insiders have sold a total of 92,340 shares of company stock valued at $2,189,064 in the last ninety days. Insiders own 3.50% of the company’s stock.
Large investors have recently added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Wright Medical Group N.V. by 11.6% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,797 shares of the medical device company’s stock valued at $104,000 after buying an additional 396 shares during the period. First Mercantile Trust Co. increased its stake in Wright Medical Group N.V. by 21.7% in the second quarter. First Mercantile Trust Co. now owns 4,380 shares of the medical device company’s stock worth $120,000 after purchasing an additional 780 shares during the period. Fortaleza Asset Management Inc. purchased a new stake in Wright Medical Group N.V. in the second quarter worth $148,000. US Bancorp DE increased its stake in Wright Medical Group N.V. by 41.3% in the second quarter. US Bancorp DE now owns 5,624 shares of the medical device company’s stock worth $155,000 after purchasing an additional 1,644 shares during the period. Finally, Prudential Financial Inc. purchased a new stake in Wright Medical Group N.V. in the first quarter worth $219,000.
About Wright Medical Group N.V.
Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.
Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with our FREE daily email newsletter.